Project Grant K23DA061913
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $196,560 to the Regents of the University of Michigan on May 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a K23 career development award for Dr. Katherine McCurry. This award provides mentorship, training, and resources to establish an independent research program focused on affective neuroscience and translational approaches to substance use disorder (SUD) prevention and...
- Federal Grant Award Summary This $2.56 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports advanced meta-analytic research to improve treatment outcomes for individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders (SUD). Awarded to Rutgers, The State University on June 1, 2025, with completion targeted for February 28, 2029, the project addresses significant...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a Project Grant totaling $144,252 to the University of Massachusetts Medical School (UMMS) under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 1, 2025, with a completion date of August 31, 2030. This mentoring-focused award supports Dr. Carreiro's research program in precision medicine and digital biomarkers for opioid use disorder (OUD) prevention and treatment. The grant funds three integrated...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $196,020 Project Grant (K23 career development award) to the University of Pennsylvania effective September 1, 2025, through August 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports Dr. Eleanor Turi, PhD, RN, CCRN in conducting mentored research training to identify low-barrier wound care models associated with positive patient outcomes among people who inject drugs...
- Federal Project Grant Award Summary The RAND Corporation received a $408,679 project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, and concluding August 31, 2027. This research initiative, titled "Adaptive Interventions for Co-Occurring Opioid Use Disorder and Post-Traumatic Stress Disorder," aims to develop scalable and equitable adaptive treatment strategies for patients...
- Federal Grant Award Summary The University of California, San Diego received a $158,246 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period July 1, 2025 through June 30, 2027. This award supports research investigating the co-occurrence of posttraumatic stress disorder (PTSD) and substance use disorder (SUD) across developmental stages from childhood through adulthood. The project adopts a developmental...
- Federal Project Grant Award Summary Boston University received a $193,751 Career Development Award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning May 1, 2026 and concluding April 30, 2031. This grant supports the development of an independent researcher focused on improving substance use disorder (SUD) services through a rigorous training and research program. The primary deliverables include research examining variation in...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Scripps Research Institute a Project Grant of $288,107 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period July 1, 2025 through June 30, 2030. This predoctoral training grant establishes a comprehensive scientific training program designed to develop the next generation of addiction research leaders. The program employs a mentor mosaic model that integrates expertise across multiple...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Mentored Research Scientist Development Award (K01) totaling $399,600 under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year career development and mentored research initiative. Awarded on August 15, 2025, with completion targeted for July 31, 2030, this grant funds Dr. Jason Brian Gibbons at the University of Colorado Anschutz Medical Campus to develop machine learning-based...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $472,370 Project Grant to Harvard T.H. Chan School of Public Health, with an award date of September 1, 2025, and completion date of August 31, 2027. Under the Drug Use and Addiction Research Programs (CFDA 93.279), this award funds implementation and evaluation of the Worker Input and Strategy Program (WISP), an evidence-based, participatory organizational intervention designed to address workforce...
The National Institute on Drug Abuse (NIDA) awarded a Career Development Award (K23) of $193,320 to The McLean Hospital Corporation, effective March 1, 2026 through February 28, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). Dr. Robyn Ellis will conduct integrated training and research activities at McLean Hospital and Harvard Medical School to develop expertise in mechanistic clinical trials for co-occurring substance use disorder and posttraumatic stress disorder (SUD-PTSD) treatment. The training component includes advanced instruction in clinical trials methodology, statistical analysis for mechanistic trials, autonomic nervous system assessment, and sex-based influences on SUD and PTSD under mentorship from established experts in these domains. As the research application of training acquired, Dr. Ellis will conduct a pilot randomized controlled trial (RCT) evaluating Written Exposure Therapy (WET), a brief PTSD treatment, embedded within residential substance use treatment settings for women with co-occurring SUD-PTSD. The research addresses critical knowledge gaps regarding whether established PTSD treatment mechanisms function similarly in populations with comorbid substance use disorders and examines the influence of estradiol on fear extinction as a putative mechanism of PTSD treatment. This project directly supports NIDA's priorities in developing improved behavioral interventions and understanding mechanisms underlying substance use and comorbid mental health conditions.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $193.3k | 2/19/26 |